181 related articles for article (PubMed ID: 10089921)
21. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
22. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation.
Mori T; Okamoto S; Watanabe R; Yajima T; Iwao Y; Yamazaki R; Nakazato T; Sato N; Iguchi T; Nagayama H; Takayama N; Hibi T; Ikeda Y
Bone Marrow Transplant; 2002 May; 29(9):777-82. PubMed ID: 12040476
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Ng AP; Worth L; Chen L; Seymour JF; Prince HM; Slavin M; Thursky K
Haematologica; 2005 Dec; 90(12):1672-9. PubMed ID: 16330442
[TBL] [Abstract][Full Text] [Related]
24. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
Ju HY; Kang HJ; Hong CR; Lee JW; Kim H; Park KD; Shin HY; Park JD; Choi EH; Lee HJ; Ahn HS
Transpl Infect Dis; 2016 Jun; 18(3):396-404. PubMed ID: 27041364
[TBL] [Abstract][Full Text] [Related]
25. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
[TBL] [Abstract][Full Text] [Related]
26. Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation.
Tanaka Y; Kanda Y; Kami M; Mori S; Hamaki T; Kusumi E; Miyakoshi S; Nannya Y; Chiba S; Arai Y; Mitani K; Hirai H; Mutou Y;
Bone Marrow Transplant; 2002 Sep; 30(5):315-9. PubMed ID: 12209354
[TBL] [Abstract][Full Text] [Related]
27. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease.
Landry ML; Ferguson D
J Clin Microbiol; 1993 Nov; 31(11):2851-6. PubMed ID: 8263166
[TBL] [Abstract][Full Text] [Related]
28. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.
Kanda Y; Mineishi S; Saito T; Seo S; Saito A; Suenaga K; Ohnishi M; Niiya H; Nakai K; Takeuchi T; Kawahigashi N; Shoji N; Ogasawara T; Tanosaki R; Kobayashi Y; Tobinai K; Kami M; Mori S; Suzuki R; Kunitoh H; Takaue Y
Bone Marrow Transplant; 2001 Feb; 27(4):437-44. PubMed ID: 11313674
[TBL] [Abstract][Full Text] [Related]
29. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
30. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.
van der Bij W; Schirm J; Torensma R; van Son WJ; Tegzess AM; The TH
J Clin Microbiol; 1988 Dec; 26(12):2531-5. PubMed ID: 2852670
[TBL] [Abstract][Full Text] [Related]
31. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
32. Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors.
Shimokawa T; Morishima Y; Kitaori K; Kato C; Sao H
Int J Hematol; 1999 Aug; 70(2):119-26. PubMed ID: 10497851
[TBL] [Abstract][Full Text] [Related]
33. [The antigenemia test for cytomegalovirus].
Pérez JL; Salvà J; Niubó J
Enferm Infecc Microbiol Clin; 1994 May; 12(5):251-61. PubMed ID: 8049289
[No Abstract] [Full Text] [Related]
34. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
Antretter H; Höfer D; Klaus A; Larcher C; Margreiter J; Margreiter R
Dtsch Med Wochenschr; 2000 Apr; 125(15):445-51. PubMed ID: 10800441
[TBL] [Abstract][Full Text] [Related]
35. [Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].
Vejražková E; Hubáček P; Kutová R; Plíšková L; Košťál M; Štěpánová V; Zavřelová A; Radocha J; Malá E; Žák P
Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):160-8. PubMed ID: 26448304
[TBL] [Abstract][Full Text] [Related]
36. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients.
Niubò J; Pérez JL; Martínez-Lacasa JT; García A; Roca J; Fabregat J; Gil-Vernet S; Martín R
Diagn Microbiol Infect Dis; 1996 Jan; 24(1):19-24. PubMed ID: 8988759
[TBL] [Abstract][Full Text] [Related]
37. [Clinical study of low cytomegalovirus viral load thresholds for preemptive antiviral therapy in hematopoietic cell transplant recipients].
Li L; Wang Y; Yan CH; Huang XJ
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):191-195. PubMed ID: 29518863
[No Abstract] [Full Text] [Related]
38. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients.
Bonon SH; Rossi CL; de Souza CA; Vigorito AC; Costa SC
Rev Inst Med Trop Sao Paulo; 2006; 48(5):275-8. PubMed ID: 17086316
[TBL] [Abstract][Full Text] [Related]
39. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients.
Ishii K; Onishi Y; Miyamura N; Fukuhara N; Ishizawa K; Nakanishi M; Ohnaka S; Miyasaka T; Kanno E; Kawakami K; Harigae H; Kaku M
J Med Virol; 2017 Jul; 89(7):1265-1273. PubMed ID: 28165158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
